Description: Pharmaceutical biotechnology requirements are high, including aseptic process management, optimum cleaning capability, closed product handling, compliance with GMP requirements, gentle product treatment, the efficient recovery of active ingredients, and reliable scale-up. With technology and equipment designed specifically for this vaccination sector, GEA stands for total compliance with these requirements.
Energizing pharma: GEA solutions in vaccine processing
June 21, 2021
10:00 - 11:00 CET
Zoom
Organisation:
GEA Group
Dr Markus Kuehberger
Senior Director Business Line Chemical & Pharma, BU Separators, GEA Group
Markus Kuehberger joined GEA in 2004 as a Sales Engineer in the Vienna office in Austria. Since 2019, he has been responsible as a Senior Director for the business line Chemical & Pharma at GEA Westfalia Separator Group in Oelde, Germany. GEA is a market leader in centrifugal separation with a strong footprint in pharmaceutical downstream processing. The topic of today´s webinar is innovative GEA single-use separators for vaccine processes reducing filtration without Steaming in Place (SIP) or Cleaning in Place (CIP). Proven disk stack technology, user-friendly design, and a small footprint in expensive clean room environments were the main drivers of this development. The system was proven to be suitable for perfusion processes already up to 30 days.
Mr. Joerg Kuepper
Sales Manager, GEA Lyophil GmbH
I have started my professional career at GEA in 2006 as a student trainee in the field of mechanical engineer which I concluded in 2012 with my M.Sc in International Project Engineering and Management. After that, I started working in Sales for GEA Lyophil. Since I am Sales Manager for all our clients from Australia, Japan, and DACH.
